Back to search results


A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-S)

RHBS | {{ defaultRegistry.registryAnchorText }} NCT02561806 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The main purpose of this study is to evaluate the efficacy of the study drug ixekizumab compared to ustekinumab in participants with moderate-to-severe-plaque psoriasis

Completed Study

The results of this study are not yet available.

Time Commitment

Your participation could last up to 52 weeks plus a minimum of 12 weeks for post treatment follow up visits and include 18 required visits to the study center

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study


Male Female


18+ years
  • Participant must have chronic plaque psoriasis for at least 6 months before the start of the study

  • Participant must agree to use reliable method of birth control during the study; women must continue using birth control for at least 15 weeks after stopping study treatment

  • Participant cannot have forms of psoriasis other than plaque psoriasis

  • Participant must not have received ustekinumab (Stelara) or already been treated with ixekizumab or another drug with a similar mode of action

  • Participant must be willing to avoid excessive sun exposure or use of tanning booths for at least 4 weeks prior to enrollment and during the study

  • Participant must not have a known allergy or hypersensitivity to latex

  • Participant must not have had any major surgery within 8 weeks of baseline or will require such during the study

  • Female participant must not be pregnant, lactating or breast-feeding

Where This Study Took Place Tool Tip Icon

Where This Study Took Place Tool Tip Icon

Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.